3 ·Filed Jun 15, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
No immediate trading signal. The filing merely satisfies SEC insider reporting requirements. Monitor future insider transaction filings (Form 4/5) for material trading activity.
Final — all horizons settled through T+60d ⚠ clustered
SLBT ▼ -21.62% at T+60d
NEUTRAL call -21.62% · α vs SPY -22.62% · entry $3.33 → $2.61
T+1d
+166.97%
call +166.97% · α +167.56%
$8.89
settled 4mo ago
T+5d
+35.74%
call +35.74% · α +37.12%
$4.52
settled 4mo ago
T+20d
+30.03%
call +30.03% · α +30.78%
$4.33
settled 4mo ago
T+60d
-21.62%
call -21.62% · α -22.62%
$2.61
settled 7w ago
Price Chart
Loading chart...
Executive Summary
Joseph Levinson filed an initial statement of beneficial ownership (Form 3) for SL Science Holding Ltd (SLBT), a Taiwan-based biologics company. The filing is a routine requirement for insiders and does not disclose any securities or trading activity.
Key Facts
- Joseph Levinson filed an initial statement of beneficial ownership on 2026-06-15
- No securities or ownership amounts are reported on the Form 3
- SL Science Holding Ltd is classified as a biological products company
Financial Impact
No financial impact — the filing reports zero beneficial ownership and no transactions
Risk Factors
- Potential future insider sales if Levinson acquires and subsequently disposes of shares
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001377558-26-000003 |
| Document: 0001377558-26-000003-index.html | 0001377558-26-000003 |
| Document: 0001377558-26-000003.txt | 0001377558-26-000003 |
10 reports for SLBT
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $1.24 | awaiting T+20 | — | $1.23 (−0.81%) |
Oct 26, 2026 1d ago | Press Release | $1.24 | awaiting T+20 | — | $1.23 (−0.81%) |
Oct 1, 2026 26d ago | SC 13D/A | $1.57 | awaiting T+20 | — | $1.23 (−21.66%) |
Aug 13, 2026 10w ago | EFFECT | $2.71 $2.06 | ▼ −23.99% | ▼ −22.24% | $1.23 (−54.61%) |
Jul 31, 2026 12w ago | F-1 | $3.29 $2.73 | ▼ −17.02% | ▼ −18.26% | $1.23 (−62.61%) |
Jul 10, 2026 15w ago | 6-K | $4.73 $2.67 | ▼ −43.55% | ▼ −45.98% | $1.23 (−74.00%) |
Jun 18, 2026 18w ago | 20-F | $4.52 $4.30 | ▼ −4.87% | ▼ −4.72% | $1.23 (−72.79%) |
Jun 17, 2026 18w ago | 3 | $6.38 $4.33 | ▼ −32.13% | ▼ −33.45% | $1.23 (−80.72%) |
Jun 15, 2026 19w ago | 3 | $3.33 $4.33 | ▲ +30.03% | ▲ +30.78% | $1.23 (−63.06%) |
Jun 15, 2026 19w ago | 6-K | $3.33 $4.33 | ▲ +30.03% | ▲ +30.78% | $1.23 (−63.06%) |
Showing 10 of 10
US Market Status
Market Closed — Opens Thu (10h 21m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers